FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma
Author:
Publisher
Wiley
Subject
Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1995.tb00269.x/fullpdf
Reference26 articles.
1. The effect of intensive intermittent maintenance therapy in advanced low-grade non- Hodgkins lymphoma;Ezdinli;Cancer,1987
2. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkins lymphoma. A randomized prospective study with an assessment of prognostic factors;Steward;Cancer,1988
3. Mitoxantrone in refractory non- Hodgkins lymphoma. A southwest oncology group study;Coltman;Sem Oncol,1984
4. Mitoxantrone in malignant lymphoma;Gams;Invest New Drugs,1985
5. Multicenter clinical trial of mitoxantrone in non-Hodgkins lymphoma and Hodgkins disease;Silver;J Clin Oncol,1991
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden;Cancer;2010-08-19
2. Results of a fludarabine induction and α-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma;European Journal of Haematology;2009-04-24
3. Clinical implications of serum levels of soluble CD23 and tumor necrosis factor alpha in low-grade non-Hodgkin's lymphoma;European Journal of Haematology;2009-04-24
4. A phase 2 trial of fludarabine and mitoxantrone chemotherapy followed by yttrium-90 ibritumomab tiuxetan for patients with previously untreated, indolent, nonfollicular, non-Hodgkin lymphoma;Cancer;2008
5. Effectiveness of Fludarabine, Idarubicin and Cyclophosphamide (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin's Lymphoma;Leukemia & Lymphoma;2004-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3